See AI PK Reports in action
Watch how AI PK Reports uses generative AI to turn tables, figures, and listings into…
CertaraAugust 28, 2026
From blank page to working model, fast
Watch how Model Designer brings cloud based pharmacometric modeling to your browser, with guided wizards,…
CertaraAugust 28, 2026
Why pharmacometrics automation is the foundation of modern PK/PD
Pharmacometrics automation is reshaping PK/PD workflows. Explore five principles driving AI, cloud infrastructure, and model…
Sebastian KuechenmeisterAugust 28, 2026
De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)
Learn how Model-based meta-analysis (MBMA) helped optimize Phase 3 trial design, dose selection, and development…
Danielle PillsburyAugust 28, 2026
Medtech market access: why strategy can’t wait for regulatory approval
Medtech market access strategy must start long before approval. See how medical device reimbursement pathways…
Eduardo UrbinaAugust 26, 2026
Three CDISC standards are converging in 2026. Here’s how to stay ahead of it.
Three major CDISC standards are converging in 2026. Here's a practical framework for managing the…
Wendy YoungAugust 26, 2026
The five drug development questions that bring sponsors to pharmacometrics
Sponsors rarely come to pharmacometrics because they need a model. They come with a development…
Rik de GreefAugust 24, 2026
Model-Informed Decision Making from Drug Discovery to Reimbursement: A Roadmap for Clinical Pharmacology in Value-Based Healthcare
Certara experts outline how model-informed drug development (MIDD) links discovery, regulatory approval, and reimbursement to…
CertaraAugust 24, 2026
Beyond Trial and Error: Model-Informed Formulation Development in Practice
Learn how model-informed formulation development and PBPK modeling can guide formulation strategy, bioequivalence, and biowaiver…
Siri Kalyan ChirumamillaAugust 24, 2026
